cobis-p011-11.html
Medicon Valley_dec-jan
12 / 16
and the winner is… cancer
research
edit. by viggo mortensen first presentation of
roche
science award the three winners of the fi rst
roche
pharma
research
& development (
pred
) oncology awards in the fi eld of ‘novel highly tumour-selective membrane targets for antibody-based cancer therapy’ have been selected. krishna chaitanya of the oncological institute at the university hospital zurich received the fi rst prize for his outstanding studies on a radioisotope-coupled antibody against fi broblast activation protein (fap), which provide a new approach to attacking tumor stroma. tumor stroma consists of cells which support the growth of tumors. the 2nd prize went to christian jost of the institute of biochemistry at the university of zurich for a completely novel concept enabling the inactivation of the her2 receptor with small, non-antibody based binding molecules. vineeta bhasker tripathi from the ucl institute of ophthalmology in london received the 3rd prize for her studies on the validation of lrg 1 (leucine-rich alpha-2-glycoprotein-1) as a new target molecule for the suppression of blood vessel formation in tumors with the aid of function-inhibiting antibodies. an extraordinary result the competitors judged to be the ten best presented their studies in mid-november at the penzberg
roche
works to an audience of experts. a panel of university
research
ers and
roche
experts chose the three victors. at the award ceremony in the evening, they received cash awards to the tune of 4,000, 2,000 and 1,000 euro. - we are delighted by the outstanding quality and great number of submissions on this vital cancer
research
topic, commented klaus bosslet, head of discovery oncology, and initiator of the award. - for the fi rst award of a prize, this is an extraordinary result. the
pred
oncology science award for outstanding european
research
work in the fi eld of antibody-based cancer therapy was presented for the fi rst time this year by the discovery oncology unit in penzberg. it honors innovative cancer
research
and emphasizes the commitment to more intensive collaboration with higher education institutions which
roche
has been advocating for years.
roche
plans to continue the successful event in 2014 with a new exciting subject.
roche
pred
roche
’s pharma
research
and early development organization – ro- che
pred
– consists of some 2,500 scientists and clinicians with a shared vision of excellence in science, a proud heritage of healthcare innovation and a commitment to deliver new and effective medicines to patients. working in partnership with
roche
’s world-leading diagnostics division,
roche
pred
strives to make personalized healthcare a reality, and change the practice of medicine for future generations.
roche
pred
focuses on four therapeutic areas: oncology, neuroscience, virology and cardiovascular-metabolism at six strategic sites worldwide. for more information: www.
roche
.com irvtswqt lwvo?wqtosuvp gspwvunwturvk ilg irvtswqt j@n@wsq$ gspwvunwturvk ijg irvnomtwvq, n@s+uq@n dhfk f dlfk f f dmr>wm u'/rst r? cf; wva ;lf dmr>wm woautuvp lwvo?wqtosuvpk ?ummuvpk /wq&wpuvp wva auntsu>oturv (:82348<";8<0#:8':<9&;24%# :3$<9";;$<%;'0:3&4 ,/9)-6+.7* 7( hj5eejdccjh0#e *7 1 h34):7< b-j0bg2l "9 .6= (% 6: == << 1 e9 b8!b84leh;ic25h3 5551,/9)-6+.7*16! andreasen & elmgaard a/s andreasen & elmgaard a/s generatorvej 8c, 2. th. dk-2730 herlev tel.:+45 7026 1235 we provide highly qualified engineering consultancy within all disciplines relating to project management, gmp compliance, technical advice, production efficiency and process verification in the pharmaceutical, biotechnological, medical device and food industry. hygienic design supply systems validation quality management process optimization maintenance audit process monitoring critical control points gmp basic design cip/sip quality assurance contact materials fda iso risk assessment project management qualification fat/sat iq/oq/pq cleaning validation continuous improvement washing machines urs lean annual review 13-14 / december-january / p12
cells-dna-replication-13.html